103 related articles for article (PubMed ID: 32505571)
1. Esophageal cancer cells convert the death signal from TRAIL into a stimulus for survival during acid/bile exposure.
Chang Z; Dang T; Che N; Yu H; Chai J; Chen W
Dig Liver Dis; 2020 Oct; 52(10):1195-1200. PubMed ID: 32505571
[TBL] [Abstract][Full Text] [Related]
2. Acid/bile exposure triggers TRAIL-mediated apoptosis in esophageal cancer cells by suppressing the decoy receptors and c-FLIP
Meng X; Chang Z; Che N; Wu J; Dang T; Chai J
Int J Biochem Cell Biol; 2020 May; 122():105736. PubMed ID: 32135301
[TBL] [Abstract][Full Text] [Related]
3. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM
J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432
[TBL] [Abstract][Full Text] [Related]
4. CCN1 sensitizes esophageal cancer cells to TRAIL-mediated apoptosis.
Dang T; Modak C; Meng X; Wu J; Narvaez R; Chai J
Exp Cell Res; 2017 Dec; 361(1):163-169. PubMed ID: 29055676
[TBL] [Abstract][Full Text] [Related]
5. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
6. Effect of Embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells.
Jiang L; Hao JL; Jin ML; Zhang YG; Wei P
Asian Pac J Cancer Prev; 2013; 14(10):6115-20. PubMed ID: 24289635
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
[TBL] [Abstract][Full Text] [Related]
8. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.
Jin TG; Kurakin A; Benhaga N; Abe K; Mohseni M; Sandra F; Song K; Kay BK; Khosravi-Far R
J Biol Chem; 2004 Dec; 279(53):55594-601. PubMed ID: 15485835
[TBL] [Abstract][Full Text] [Related]
9. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
Harper N; Hughes M; MacFarlane M; Cohen GM
J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
[TBL] [Abstract][Full Text] [Related]
10. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
Sprick MR; Weigand MA; Rieser E; Rauch CT; Juo P; Blenis J; Krammer PH; Walczak H
Immunity; 2000 Jun; 12(6):599-609. PubMed ID: 10894160
[TBL] [Abstract][Full Text] [Related]
11. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
Kim JH; Ajaz M; Lokshin A; Lee YJ
Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
MacFarlane M; Harper N; Snowden RT; Dyer MJ; Barnett GA; Pringle JH; Cohen GM
Oncogene; 2002 Oct; 21(44):6809-18. PubMed ID: 12360407
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
[TBL] [Abstract][Full Text] [Related]
14. Molecular Dynamics in Esophageal Adenocarcinoma: Who's in Control?
Dang T; Chai J
Curr Cancer Drug Targets; 2020; 20(10):789-801. PubMed ID: 32691711
[TBL] [Abstract][Full Text] [Related]
15. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
Ozoren N; Kim K; Burns TF; Dicker DT; Moscioni AD; El-Deiry WS
Cancer Res; 2000 Nov; 60(22):6259-65. PubMed ID: 11103780
[TBL] [Abstract][Full Text] [Related]
16. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A
Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma.
Kondo K; Yamasaki S; Sugie T; Teratani N; Kan T; Imamura M; Shimada Y
Int J Cancer; 2006 Jan; 118(1):230-42. PubMed ID: 16003725
[TBL] [Abstract][Full Text] [Related]
18. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
19. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.
Schneider P; Thome M; Burns K; Bodmer JL; Hofmann K; Kataoka T; Holler N; Tschopp J
Immunity; 1997 Dec; 7(6):831-6. PubMed ID: 9430228
[TBL] [Abstract][Full Text] [Related]
20. Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human esophageal epithelial cells.
Kim SH; Kim K; Kwagh JG; Dicker DT; Herlyn M; Rustgi AK; Chen Y; El-Deiry WS
J Biol Chem; 2004 Sep; 279(38):40044-52. PubMed ID: 15226295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
